Biomind Labs Inc. (CVE:BMND.NE) | Finanzwire

Basculer en Français

10496	Companies
221321	Keywords
150507	Articles
117035	Press releases

Home
Companies
Biomind Labs Inc.

BRIEF

published on 11/21/2024 at 00:30, 1 year 6 months ago

Biomind Labs Sees Opportunity in U.S. Policy Shift for Psychedelic Therapies

FDA Approval Psychedelic Therapies Neurological Disorders BMND08 Drug U.S. Policy Shift
PRESS RELEASE

published on 11/21/2024 at 00:25, 1 year 6 months ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Biomind Labs Inc., a leading biotech company, optimistic about U.S. government's stance on psychedelic industry. Company's BMND08 shows promising results in Phase II trial for neuropsychiatric disorders

FDA Neuropsychiatric Disorders Biomind Labs Inc. BMND08 Psychedelic Industry
BRIEF

published on 07/18/2024 at 14:35, 1 year 10 months ago

Biomind Labs Advances New Obesity Treatment with BMND06 Candidate Targeting Neurological Pathways

Obesity Treatment Clinical Trial Biomind Labs BMND06 Anti-inflammatory
PRESS RELEASE

published on 07/18/2024 at 14:30, 1 year 10 months ago

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
Biomind Labs announced the decision to advance a Phase II clinical trial for BMND06, a novel compound with potential anti-inflammatory properties for treating obesity and neurological disorders

Phase II Trial Obesity Biomind Labs BMND06 Anti-inflammatory

Accesswire

Published on 06/03/2026 at 10:00, 18 minutes ago

Eagle Plains and Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, SK
Published on 06/03/2026 at 09:05, 1 hour 13 minutes ago

2026 Letter to Nano One Stakeholders
Published on 06/03/2026 at 09:01, 1 hour 17 minutes ago

Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 5 hours 20 minutes ago

Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 10 hours 18 minutes ago

Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program

View all ACCESSWIRE

EQS Group

Published on 06/03/2026 at 10:05, 12 minutes ago

SLOVAKIAN BAR WINS INAUGURAL EUROPE'S 50 BEST BARS MICHTER'S ART OF HOSPITALITY AWARD
Published on 06/03/2026 at 10:00, 18 minutes ago

World Bronchiectasis Conference 2026 returns to Hannover: 10 years of progress from neglected disease to global movement
Published on 06/03/2026 at 09:40, 37 minutes ago

Medios AG: Contract of Executive Board Member Constantijn van Rietschoten extended ahead of schedule
Published on 06/03/2026 at 09:30, 47 minutes ago

LION E-Mobility AG: Ian Mukherjee to assume Role of Chairman of the Board of Directors
Published on 06/03/2026 at 09:30, 48 minutes ago

Skyborn Renewables appoints Michael Klingele as Chief Operating Officer

Les Echos

Published on 06/03/2026 at 08:45, 1 hour 33 minutes ago

Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 16 hours 14 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 16 hours 36 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 16 hours 38 minutes ago

Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 2 hours ago

EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET

View all LES ECHOS COMFI WIRE